RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS |
NOTE 2. RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS
The Company previously accounted for its outstanding Private Placement Warrants issued in connection with its Initial Public Offering as components of equity instead of as derivative liabilities. The warrant agreement governing the warrants includes a provision that provides for potential changes to the settlement amounts dependent upon the characteristics of the holder of the warrant. In addition, the warrant agreement includes a provision that in the event of a tender or exchange offer made to and accepted by holders of more than 50% of the outstanding shares of a single class of common shares, all holders of the warrants would be entitled to receive cash for their warrants (the “tender offer provision”).
On April 12, 2021, the SEC released a Staff Statement on Accounting and Reporting Considerations for Warrants Issued by Special Purpose Acquisition Companies (the “SEC Staff Statement”). Specifically, the SEC Staff Statement focused on certain settlement terms and provisions related to certain tender offers following a business combination, which terms are similar to those contained in the warrant agreement governing our warrants. Following the SEC Staff Statement, the Company’s management further evaluated the warrants under Accounting Standards Codification (“ASC”) Subtopic 815-40, Contracts in Entity’s Own Equity. ASC Section 815-40-15 addresses equity versus liability treatment and classification of equity-linked financial instruments, including warrants, and states that a warrant may be classified as a component of equity only if, among other things, the warrant is indexed to the issuer’s common stock. Under ASC Section 815-40-15, a warrant is not indexed to the issuer’s common stock if the terms of the warrant require an adjustment to the exercise price upon a specified event and that event is not an input to the fair value of the warrant. Based on management’s evaluation, the Company’s audit committee, in consultation with management, concluded that the Company’s Private Placement Warrants are not indexed to the Company’s common shares in the manner contemplated by ASC Section 815-40-15 because the holder of the instrument is not an input into the pricing of a fixed-for-fixed option on equity shares. In addition, based on management’s evaluation, the Company’s audit committee, in consultation with management concluded the tender offer provision included in the warrant agreement fails the “classified in shareholders’ equity” criteria as contemplated by ASC Section 815-40-25.
As a result of the above, the Company should have classified the private warrants as derivative liabilities in its previously issued financial statements. Under this accounting treatment, the Company is required to measure the fair value of the warrants at the end of each reporting period and recognize changes in the fair value from the prior period in the Company’s operating results for the current period.
The Company’s accounting for the private warrants as components of equity instead of as derivative liabilities did not have any effect on the Company’s previously reported operating expenses, cash flows or cash.
|
|
|
|
|
|
|
|
|
|
Balance Sheet as of
|
|
|
|
|
|
|
|
|
|
October 22, 2019
|
|
As Reported
|
|
Adjustment
|
|
As Restated
|
|
|
|
|
|
|
|
|
|
|
Warrant Liabilities
|
|
$
|
—
|
|
$
|
1,356,300
|
|
$
|
1,356,300
|
Total Liabilities
|
|
|
82,127
|
|
|
1,356,300
|
|
|
1,438,427
|
Ordinary shares subject to redemption
|
|
|
133,895,920
|
|
|
(1,356,300)
|
|
|
132,539,620
|
Ordinary Shares
|
|
|
401
|
|
|
14
|
|
|
415
|
Additional paid-in capital
|
|
$
|
5,052,511
|
|
$
|
4,064
|
|
$
|
5,056,575
|
Retained earnings (Accumulated deficit)
|
|
|
(52,908)
|
|
|
(4,078)
|
|
|
(56,986)
|
Total Shareholders’ Equity
|
|
$
|
5,000,004
|
|
$
|
—
|
|
$
|
5,000,004
|
|
|
|
|
|
|
|
|
|
|
Number of shares subject to possible redemption
|
|
|
13,389,592
|
|
|
(135,630)
|
|
|
13,253,962
|
|
|
|
|
|
|
|
|
|
|
Balance Sheet as of
|
|
|
|
|
|
|
|
|
|
December 31, 2019
|
|
As Reported
|
|
Adjustment
|
|
As Restated
|
Warrant Liabilities
|
|
$
|
—
|
|
$
|
1,972,800
|
|
$
|
1,972,800
|
Total Liabilities
|
|
|
65,716
|
|
|
1,972,800
|
|
|
2,038,516
|
Ordinary shares subject to redemption
|
|
|
134,190,490
|
|
|
(1,972,800)
|
|
|
132,217,690
|
Ordinary Shares
|
|
|
398
|
|
|
20
|
|
|
418
|
Additional paid-in capital
|
|
$
|
4,757,944
|
|
$
|
620,558
|
|
$
|
5,378,502
|
Retained earnings (Accumulated deficit)
|
|
$
|
241,659
|
|
$
|
(620,578)
|
|
$
|
(378,919)
|
Total Shareholders’ Equity
|
|
$
|
5,000,001
|
|
$
|
—
|
|
$
|
5,000,001
|
|
|
|
|
|
|
|
|
|
|
Number of shares subject to possible redemption
|
|
|
13,419,049
|
|
|
(197,280)
|
|
|
13,221,769
|
|
|
|
|
|
|
|
|
|
|
Statement of Operations for the
|
|
|
|
|
|
|
|
|
|
period from July 30, 2019 (inception) to December 31, 2019
|
|
As Reported
|
|
Adjustment
|
|
As Restated
|
Transaction costs allocable to warrant liabilities
|
|
$
|
—
|
|
$
|
(4,078)
|
|
$
|
(4,078)
|
Change in fair value of warrant liabilities
|
|
|
—
|
|
|
(616,500)
|
|
|
(616,500)
|
Net income
|
|
$
|
241,659
|
|
$
|
(620,578)
|
|
$
|
(378,919)
|
Basic and diluted net loss per ordinary share, non-redeemable
|
|
$
|
(0.05)
|
|
$
|
(0.17)
|
|
$
|
(0.22)
|
|
|
|
|
|
|
|
|
|
|
Statement of Cash Flows for the
|
|
|
|
|
Period
|
|
|
|
year ended December 31, 2019
|
|
As Reported
|
|
|
Adjustment
|
|
As Restated
|
Net income (loss)
|
|
$
|
241,659
|
|
$
|
(620,578)
|
|
$
|
(378,919)
|
Change in fair value of warrant liabilities
|
|
$
|
—
|
|
$
|
616,500
|
|
$
|
616,500
|
Transaction costs allocable to warrant liabilities
|
|
$
|
—
|
|
$
|
4,078
|
|
$
|
4,078
|
Initial classification of warrant liabilities
|
|
$
|
—
|
|
$
|
1,356,300
|
|
$
|
1,356,300
|
Initial classification of ordinary shares subject to possible redemption
|
|
$
|
133,895,920
|
|
$
|
(1,356,300)
|
|
$
|
132,539,620
|
Change in value of ordinary shares subject to possible redemption
|
|
$
|
294,570
|
|
$
|
(616,500)
|
|
$
|
(321,930)
|
|
|
|
|
|
|
|
|
|
|
Balance Sheet as of
|
|
|
|
|
Period
|
|
|
|
March 31, 2020 (unaudited)
|
|
As Reported
|
|
Adjustment
|
|
As Restated
|
Warrant Liabilities
|
|
$
|
—
|
|
$
|
1,027,500
|
|
$
|
1,027,500
|
Total Liabilities
|
|
|
53,215
|
|
|
1,027,500
|
|
|
1,080,715
|
Ordinary shares subject to redemption
|
|
|
134,537,080
|
|
|
(1,027,500)
|
|
|
133,509,580
|
Ordinary Shares
|
|
|
395
|
|
|
10
|
|
|
405
|
Additional paid-in capital
|
|
$
|
4,411,357
|
|
$
|
(324,732)
|
|
$
|
4,086,625
|
Retained earnings
|
|
$
|
588,253
|
|
$
|
324,722
|
|
$
|
912,975
|
Total Shareholders’ Equity
|
|
$
|
5,000,005
|
|
$
|
—
|
|
$
|
5,000,005
|
|
|
|
|
|
|
|
|
|
|
Number of shares subject to possible redemption
|
|
|
13,453,708
|
|
|
(102,750)
|
|
|
13,350,958
|
|
|
|
|
|
|
|
|
|
|
Balance Sheet as of
|
|
|
|
|
Period
|
|
|
|
June 30, 2020 (unaudited)
|
|
As Reported
|
|
Adjustment
|
|
As Restated
|
Warrant Liabilities
|
|
$
|
—
|
|
$
|
2,383,800
|
|
$
|
2,383,800
|
Total Liabilities
|
|
|
16,366
|
|
|
2,383,800
|
|
|
2,400,166
|
Ordinary shares subject to redemption
|
|
|
134,591,590
|
|
|
(2,383,800)
|
|
|
132,207,790
|
Ordinary Shares
|
|
|
394
|
|
|
24
|
|
|
418
|
Additional paid-in capital
|
|
$
|
4,356,848
|
|
$
|
1,031,554
|
|
$
|
5,388,402
|
Retained earnings (Accumulated deficit)
|
|
$
|
642,765
|
|
$
|
(1,031,578)
|
|
$
|
(388,813)
|
Total Shareholders’ Equity
|
|
$
|
5,000,007
|
|
$
|
—
|
|
$
|
5,000,007
|
|
|
|
|
|
|
|
|
|
|
Number of shares subject to possible redemption
|
|
|
13,459,159
|
|
|
(238,380)
|
|
|
13,220,779
|
|
|
|
|
|
|
|
|
|
|
Balance Sheet as of
|
|
|
|
|
Period
|
|
|
|
September 30, 2020 (unaudited)
|
|
As Reported
|
|
Adjustment
|
|
As Restated
|
Warrant Liabilities
|
|
$
|
—
|
|
$
|
2,548,200
|
|
$
|
2,548,200
|
Total Liabilities
|
|
|
15,147
|
|
|
2,548,200
|
|
|
2,563,347
|
Ordinary shares subject to redemption
|
|
|
134,531,290
|
|
|
(2,548,200)
|
|
|
131,983,090
|
Ordinary Shares
|
|
|
395
|
|
|
25
|
|
|
420
|
Additional paid-in capital
|
|
$
|
4,417,147
|
|
$
|
1,195,953
|
|
$
|
5,613,100
|
Retained earnings (Accumulated deficit)
|
|
$
|
582,459
|
|
$
|
(1,195,978)
|
|
$
|
(613,519)
|
Total Shareholders’ Equity
|
|
$
|
5,000,001
|
|
$
|
0
|
|
$
|
5,000,001
|
|
|
|
|
|
|
|
|
|
|
Number of shares subject to possible redemption
|
|
|
13,453,129
|
|
|
(254,820)
|
|
|
13,198,309
|
|
|
|
|
|
|
|
|
|
|
Balance Sheet as of
|
|
|
|
|
Period
|
|
|
|
December 31, 2020
|
|
As Reported
|
|
Adjustment
|
|
As Restated
|
Warrant Liabilities
|
|
$
|
—
|
|
$
|
3,452,400
|
|
$
|
3,452,400
|
Total Liabilities
|
|
|
709,732
|
|
|
3,452,400
|
|
|
4,162,132
|
Ordinary shares subject to redemption
|
|
|
134,138,890
|
|
|
(3,452,400)
|
|
|
130,686,490
|
Ordinary Shares
|
|
|
399
|
|
|
34
|
|
|
433
|
Additional paid-in capital
|
|
$
|
4,809,543
|
|
$
|
2,100,144
|
|
$
|
6,909,687
|
Retained earnings (Accumulated deficit)
|
|
$
|
190,067
|
|
$
|
(2,100,178)
|
|
$
|
(1,910,111)
|
Total Shareholders’ Equity
|
|
$
|
5,000,009
|
|
$
|
—
|
|
$
|
5,000,009
|
|
|
|
|
|
|
|
|
|
|
Number of shares subject to possible redemption
|
|
|
13,413,889
|
|
|
(345,240)
|
|
|
13,068,649
|
|
|
|
|
|
|
|
|
|
|
Statement of Operations for the
|
|
|
|
|
Period
|
|
|
|
three months ended March 31, 2020 (unaudited)
|
|
As Reported
|
|
Adjustment
|
|
As Restated
|
Change in fair value of warrant liabilities
|
|
$
|
—
|
|
$
|
945,300
|
|
$
|
945,300
|
Net income
|
|
$
|
346,594
|
|
$
|
945,300
|
|
$
|
1,291,894
|
Basic and diluted net loss per ordinary share, non-redeemable
|
|
$
|
(0.06)
|
|
$
|
0.27
|
|
$
|
0.21
|
|
|
|
|
|
|
|
|
|
|
Statement of Operations for the
|
|
|
|
|
Period
|
|
|
|
six months ended June 30, 2020 (unaudited)
|
|
As Reported
|
|
Adjustment
|
|
As Restated
|
Change in fair value of warrant liabilities
|
|
$
|
—
|
|
$
|
(411,000)
|
|
$
|
(411,000)
|
Net income
|
|
$
|
401,106
|
|
$
|
(411,000)
|
|
$
|
(9,894)
|
Basic and diluted net loss per ordinary share, non-redeemable
|
|
$
|
(0.08)
|
|
$
|
(0.11)
|
|
$
|
(0.19)
|
|
|
|
|
|
|
|
|
|
|
Statement of Operations for the
|
|
|
|
|
Period
|
|
|
|
three months ended June 30, 2020 (unaudited)
|
|
As Reported
|
|
Adjustment
|
|
As Restated
|
Change in fair value of warrant liabilities
|
|
$
|
—
|
|
$
|
(1,356,300)
|
|
$
|
(1,356,300)
|
Net income
|
|
$
|
54,512
|
|
$
|
(1,356,300)
|
|
$
|
(1,301,788)
|
Basic and diluted net loss per ordinary share, non-redeemable
|
|
$
|
(0.02)
|
|
$
|
(0.38)
|
|
$
|
(0.40)
|
|
|
|
|
|
|
|
|
|
|
Statement of Operations for the
|
|
|
|
|
Period
|
|
|
|
nine months ended September 30, 2020 (unaudited)
|
|
As Reported
|
|
Adjustment
|
|
As Restated
|
Change in fair value of warrant liabilities
|
|
$
|
—
|
|
$
|
(575,400)
|
|
$
|
(575,400)
|
Net income (loss)
|
|
$
|
340,800
|
|
$
|
(575,400)
|
|
$
|
(234,600)
|
Basic and diluted net loss per ordinary share, non-redeemable
|
|
$
|
(0.10)
|
|
$
|
(0.16)
|
|
$
|
(0.26)
|
|
|
|
|
|
|
|
|
|
|
Statement of Operations for the
|
|
|
|
|
Period
|
|
|
|
three months ended September 30, 2020 (unaudited)
|
|
As Reported
|
|
Adjustment
|
|
As Restated
|
Change in fair value of warrant liabilities
|
|
$
|
—
|
|
$
|
(164,400)
|
|
$
|
(164,400)
|
Net income (loss)
|
|
$
|
(60,306)
|
|
$
|
(164,400)
|
|
$
|
(224,706)
|
Basic and diluted net loss per ordinary share, non-redeemable
|
|
$
|
(0.30)
|
|
$
|
0.23
|
|
$
|
(0.07)
|
|
|
|
|
|
|
|
|
|
|
Statement of Operations for the
|
|
|
|
|
Period
|
|
|
|
year ended December 31, 2020
|
|
As Reported
|
|
Adjustment
|
|
As Restated
|
Change in fair value of warrant liabilities
|
|
$
|
—
|
|
$
|
(1,479,600)
|
|
$
|
(1,479,600)
|
Net income (loss)
|
|
$
|
(51,592)
|
|
$
|
(1,479,600)
|
|
$
|
(1,531,192)
|
Basic and diluted net loss per ordinary share, non-redeemable
|
|
$
|
(0.22)
|
|
$
|
(0.41)
|
|
$
|
(0.63)
|
|
|
|
|
|
|
|
|
|
|
Statement of Cash Flows for the
|
|
|
|
|
|
|
|
|
|
period ended March 31, 2020 (unaudited)
|
|
As Reported
|
|
Period Adjustment
|
|
As Restated
|
Net income (loss)
|
|
$
|
346,594
|
|
$
|
945,300
|
|
$
|
1,291,894
|
Change in fair value of warrant liabilities
|
|
$
|
—
|
|
$
|
(945,300)
|
|
$
|
(945,300)
|
Change in value of ordinary shares subject to possible redemption
|
|
$
|
346,590
|
|
$
|
945,300
|
|
$
|
(1,291,890)
|
|
|
|
|
|
|
|
|
|
|
Statement of Cash Flows for the
|
|
|
|
|
|
|
|
|
|
period ended June 30, 2020 (unaudited)
|
|
As Reported
|
|
Period Adjustment
|
|
As Restated
|
Net income (loss)
|
|
$
|
401,106
|
|
$
|
(411,000)
|
|
$
|
(9,894)
|
Change in fair value of warrant liabilities
|
|
$
|
—
|
|
$
|
411,000
|
|
$
|
411,000
|
Change in value of ordinary shares subject to possible redemption
|
|
$
|
401,100
|
|
$
|
(411,000)
|
|
$
|
(9,900)
|
|
|
|
|
|
|
|
|
|
|
Statement of Cash Flows for the
|
|
|
|
|
|
|
|
|
|
period ended September 30, 2020 (unaudited)
|
|
As Reported
|
|
Period Adjustment
|
|
As Restated
|
Net income (loss)
|
|
$
|
340,800
|
|
$
|
(575,400)
|
|
$
|
(234,600)
|
Change in fair value of warrant liabilities
|
|
$
|
—
|
|
$
|
575,400
|
|
$
|
575,400
|
Change in value of ordinary shares subject to possible redemption
|
|
$
|
340,800
|
|
$
|
(575,400)
|
|
$
|
(234,600)
|
|
|
|
|
|
|
|
|
|
|
Statement of Cash Flows for the
|
|
|
|
|
|
|
|
|
|
year ended December 31, 2020
|
|
As Reported
|
|
Period Adjustment
|
|
As Restated
|
Net income (loss)
|
|
$
|
(51,592)
|
|
$
|
(1,479,600)
|
|
$
|
(1,531,192)
|
Change in fair value of warrant liabilities
|
|
$
|
—
|
|
$
|
1,479,600
|
|
$
|
1,479,600
|
Change in value of ordinary shares subject to possible redemption
|
|
$
|
(51,600)
|
|
$
|
(1,479,600)
|
|
$
|
(1,531,200)
|
|